This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2008 Aug 15;112(4):924-5.

doi: 10.1182/blood-2008-05-155721.

Further progress in CLL therapy

Emili Montserrat¹

Affiliations

PMID: 18684871
DOI: 10.1182/blood-2008-05-155721

Free article

Comment

Further progress in CLL therapy

Emili Montserrat. Blood. 2008.

Free article

. 2008 Aug 15;112(4):924-5.

doi: 10.1182/blood-2008-05-155721.

Author

Emili Montserrat¹

Affiliation

¹ University of Barcelona.

PMID: 18684871
DOI: 10.1182/blood-2008-05-155721

No abstract available

PubMed Disclaimer

Comment on

Long-term results of the fludarabine, cyclophosphamide, and rituximab regimen as initial therapy of chronic lymphocytic leukemia.
Tam CS, O'Brien S, Wierda W, Kantarjian H, Wen S, Do KA, Thomas DA, Cortes J, Lerner S, Keating MJ. Tam CS, et al. Blood. 2008 Aug 15;112(4):975-80. doi: 10.1182/blood-2008-02-140582. Epub 2008 Apr 14. Blood. 2008. PMID: 18411418 Free PMC article. Clinical Trial.

Publication types

Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
- Silverchair Information Systems